Rothstein, B. 2018. Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S110-S111. DOI:https://doi.org/10.25251/skin.2.supp.102.